BiogenBIIB 
$197.53-0.34%24h
-0.34%24h
Global rank648
Market cap$28.58B
Change 7d-1.45%
YTD Performance-23.31%
SP500 benchmarkUnderperform
P/E24.78
P/S2.91
Revenue$9.84B
Earnings$1.16B
Dividend yield-
Main Sector
Healthcare
Category
Biogen (BIIB) Total Liabilities
BIIB Total Liabilities in 2022: $12.05B
According to Biogen latest financial reports the total liabilities of BIIB is $12.05B, an increase of 7.88% to 2022. At the end of 2022 company had $11.17B total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Biogen is responsible for during its operational activities.
Biogen (BIIB) Total Liabilities History from 2023 to 2022
-
Value:-
BIIB Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $12.05B | 7.88% |
| 2022 | $11.17B | -13.56% |
| 2021 | $12.92B | -7.29% |
| 2020 | $13.93B | 0.27% |
| 2019 | $13.90B | 80.54% |
| 2018 | $7.70B | - |
View the Top Total Liabilies Stocks
